Chest wall volumes, diaphragmatic mobility, and functional capacity in patients with mucopolysaccharidoses

References

• Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology. 2011;50 Suppl 5:v4–12.
   PubMed Web of Science ®Google Scholar
• Lehman TJ, Miller N, Norquist B, et al. Diagnosis of the mucopolysaccharidoses. Rheumatology. 2011;50 Suppl 5:v41–48.
   PubMed Web of Science ®Google Scholar
• Arn P, Whitley C, Wraith JE, et al. High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I registry. J Pediatr Surg. 2012;47(3):477–484.
   PubMed Web of Science ®Google Scholar
• Jones SA, Almassy Z, Beck M, et al. Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis. 2009;32(4):534–543.
   PubMed Web of Science ®Google Scholar
• Guarany NR, Schwartz IV, Guarany FC, et al. Functional capacity evaluation of patients with mucopolysaccharidosis. J Pediatr Rehabil Med. 2012;5(1):37–46.
   PubMedGoogle Scholar
• Berger KI, Fagondes SC, Giugliani R, et al. Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis. 2013;36(2):201–210.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Pyeritz RE. Respiratory complications of mucopolysaccharide storage disorders. Medicine. 1988;67(4):209–219.
   PubMed Web of Science ®Google Scholar
• Myer CM. Airway obstruction in hurler's syndrome–radiographic features. Int J Pediatr Otorhinol. 1991;22(1):91–96.
   PubMed Web of Science ®Google Scholar
• Muhlebach MS, Wooten W, Muenzer J. Respiratory manifestations in mucopolysaccharidoses. Paediatr Respir Rev. 2011;12(2):133–138.
   PubMed Web of Science ®Google Scholar
• Hendriksz CJ, Berger KI, Lampe C, et al. Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues. Orphanet J Rare Dis. 2016;11(1):119.
   PubMedGoogle Scholar
• Martins AM, Dualibi AP, Norato D, et al. Guidelines for the management of mucopolysaccharidosis type I. J Pediatr. 2009;155(4 Suppl):S32–S46.
   PubMed Web of Science ®Google Scholar
• Stapleton M, Hoshina H, Sawamoto K, et al. Critical review of current MPS guidelines and management. Mol Genet Metab. 2019;126(3):238–245.
   PubMed Web of Science ®Google Scholar
• Kenth JJ, Thompson G, Fullwood C, et al. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: a longitudinal analysis. Mol Gen Metab Reports. 2019;20:100487.
   PubMed Web of Science ®Google Scholar
• Harmatz P, Yu ZF, Giugliani R, et al. Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis. 2010;33(1):51–60.
   PubMed Web of Science ®Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psych Res. 1975;12(3):189–198.
   Web of Science ®Google Scholar
• Cestario EdES, Santim AA, Beretta Alves B, et al. Prevalence, knowledge and treatment of systemic arterial hypertension in a campaign day. EJMED. 2022;4(1):14–20.
   Google Scholar
• Varni JW, Burwinkle TM, Seid M, et al. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Amb Ped. 2003;3(6):329–341.
   PubMedGoogle Scholar
• Fleck M, Louzada S, Xavier M, et al. Desenvolvimento da versão em português do instrumento de avaliação de qualidade de vida da OMS (WHOQOL-100). Rev Bras Psiquiatr. 1999;21(1):19–28.
   Google Scholar
• Panzini RG, Maganha C, Rocha NSd, et al. Validação brasileira do instrumento de qualidade de vida/espiritualidade, religião e crenças pessoais. Rev Saúde Pública. 2011;45(1):153–165.
   PubMedGoogle Scholar
• Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88.
   PubMed Web of Science ®Google Scholar
• Jones MH, Vidal PCV, Lanza FC, et al. Reference values for spirometry in Brazilian Children. J Bras Pneumol. 2020;46(3):e20190138.
   PubMed Web of Science ®Google Scholar
• Sociedade brasileira de pneumologia e tisiologia. Diretrizes Para testes de função pulmonar. J Pneumol. 2002;28:S 207-S 221.
   Google Scholar
• Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007;33(4):397–406.
   PubMedGoogle Scholar
• Laveneziana P, Albuquerque A, Aliverti A, et al. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J. 2019;53(6):1801214.
   PubMed Web of Science ®Google Scholar
• Lanza FC, de Moraes Santos ML, Selman JPR, et al. Reference equation for respiratory pressures in pediatric population: a multicenter study. PLOS ONE. 2015;10(8):e0135662.
   PubMed Web of Science ®Google Scholar
• Neder JA, Andreoni S, Lerario MC, et al. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999;32(6):719–727.
   PubMed Web of Science ®Google Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• de Assis Pereira Cacau L, Carvalho VO, Dos Santos Pin A, et al. Reference values for the 6-min walk distance in healthy children age 7 to 12 years in Brazil: main results of the TC6minBrasil Multi-Center study. Respir Care. 2018;63(3):339–346.
   PubMed Web of Science ®Google Scholar
• Iwama AM, Andrade GN, Shima P, et al. The six-minute walk test and body weight-walk distance product in healthy Brazilian subjects. Braz J Med Biol Res. 2009;42(11):1080–1085.
   PubMed Web of Science ®Google Scholar
• Britto RR, Probst VS, de Andrade AF, et al. Reference equations for the six-minute walk distance based on a Brazilian Multicenter Study. Braz J Phys Ther. 2013;17(6):556–563.
   PubMed Web of Science ®Google Scholar
• Aliverti A, Dellaca R, Pelosi P, et al. Optoelectronic plethysmography in intensive care patients. Am J Respir Crit Care Med. 2000;161(5):1546–1552.
   PubMed Web of Science ®Google Scholar
• Cala SJ, Kenyon CM, Ferrigno G, et al. Chest wall and lung volume estimation by optical reflectance motion analysis. J Appl Physiol. 1996;81(6):2680–2689.
   PubMed Web of Science ®Google Scholar
• Aliverti A, Dellaca R, Pelosi P, et al. Compartmental analysis of breathing in the supine and prone positions by optoelectronic plethysmography. Ann Biomed Eng. 2001;29(1):60–70.
   PubMed Web of Science ®Google Scholar
• Kenyon CM, Cala SJ, Yan S, et al. Rib cage mechanics during quiet breathing and exercise in humans. J Appl Physiol. 1997;83(4):1242–1255.
   PubMed Web of Science ®Google Scholar
• Aliverti A, Cala SJ, Duranti R, et al. Human respiratory muscle actions and control during exercise. J Appl Physiol. 1997;83(4):1256–1269.
   PubMed Web of Science ®Google Scholar
• Matamis D, Soilemezi E, Tsagourias M, et al. Sonographic evaluation of the diaphragm in critically ill patients. Technique and clinical applications. Intensive Care Med. 2013;39(5):801–810.
   PubMed Web of Science ®Google Scholar
• Testa A, Soldati G, Giannuzzi R, et al. Ultrasound M-mode assessment of diaphragmatic kinetics by anterior transverse scanning in healthy subjects. Ultrasound Med Biol. 2011;37(1):44–52.
   PubMed Web of Science ®Google Scholar
• Raluy-Callado M, Chen WH, Whiteman DA, et al. The impact of hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life. Orphanet J Rare Dis. 2013;8:101.
   PubMed Web of Science ®Google Scholar
• Lin SP, Shih SC, Chuang CK, et al. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses–changes with age and treatment. Pediatr Pulmonol. 2014;49(3):277–284.
   PubMed Web of Science ®Google Scholar
• Figueirêdo BBRS, Magalhães PAF, Andrade LB, et al. Level of independence, functional capacity and respiratory muscle strength of patients with mucopolysaccharidosis type VI in the northeast of Brazil. Rev Bras Saude Mater Infant. 2018;18(1):83–92.
   Google Scholar
• Savci S, Ozturk M, Inal-Ince D, et al. Inspiratory muscle training in Morquio's syndrome: a case study. Pediatr Pulmonol. 2006;41(12):1250–1253.
   PubMed Web of Science ®Google Scholar
• Quartel A, Hendriksz CJ, Parini R, et al. Growth charts for individuals with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). JIMD Rep. 2015;18:1–11.
   PubMedGoogle Scholar
• Steven Sims H, Kempiners JJ. Special airway concerns in patients with mucopolysaccharidoses. Respir Med. 2007;101(8):1779–1782.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Breyer S, Löbel U, et al. Musculoskeletal manifestations in mucopolysaccharidosis type I (hurler syndrome) following hematopoietic stem cell transplantation. Orphanet J Rare Dis. 2016;11(1):93.
   PubMedGoogle Scholar
• Piotrowska E, Jakóbkiewicz-Banecka J, Tylki-Szymańska A, et al. Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis. Acta Paediatr. 2009;98(4):743–749.
   PubMed Web of Science ®Google Scholar
• Swiedler SJ, Beck M, Bajbouj M, et al. Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet. 2005;134a(2):144–150.
   PubMed Web of Science ®Google Scholar
• Harmatz P, Mengel KE, Giugliani R, et al. The morquio a clinical assessment program: baseline results illustrating progressive, multisystemic clinical impairments in morquio a subjects. Mol Genet Metab. 2013;109(1):54–61.
   PubMed Web of Science ®Google Scholar
• Muenzer J, Wraith JE, Beck M, et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome). Genet Med. 2006;8(8):465–473.
   PubMed Web of Science ®Google Scholar
• Hendriksz CJ, Burton B, Fleming TR, et al. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for morquio a syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J Inherit Metab Dis. 2014;37(6):979–990.
   PubMed Web of Science ®Google Scholar
• Lampe C, Jain M, Olaye A, et al. Relationship between patient-reported outcomes and clinical outcomes in patients with morquio a syndrome. J Inborn Errors Metab Screen. 2015;3:232640981557618.
   Google Scholar
• Concolino D, Deodato F, Parini R. Enzyme replacement therapy: efficacy and limitations. Ital J Pediatr. 2018;44(Suppl 2):120.
   PubMedGoogle Scholar
• Goemans N, Vanden Hauwe M, Signorovitch J, et al. Individualized prediction of changes in 6-minute walk distance for patients with Duchenne muscular dystrophy. PLOS One. 2016;11(10):e0164684.
   PubMed Web of Science ®Google Scholar
• Matos MA, Prado A, Schenkel G, et al. Energy expenditure during gait in patients with mucopolysaccharidosis. Acta Ortop Bras. 2013;21(2):116–119.
   PubMed Web of Science ®Google Scholar
• Camillo CA, Langer D, Osadnik CR, et al. Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes. COPD. 2016;ume 11:2671–2679.
   Google Scholar
• La Rovere MT, Pinna GD, Maestri R, et al. The 6-minute walking test and all-cause mortality in patients undergoing a post-cardiac surgery rehabilitation program. Eur J Prev Cardiolog. 2015;22(1):20–26.
   PubMed Web of Science ®Google Scholar
• Schrover R, Evans K, Giugliani R, et al. Minimal clinically important difference for the 6-min walk test: literature review and application to morquio a syndrome. Orphanet J Rare Dis. 2017;12(1):78.
   PubMedGoogle Scholar
• Boussuges A, Gole Y, Blanc P. Diaphragmatic motion studied by m-mode ultrasonography: methods, reproducibility, and normal values. Chest. 2009;135(2):391–400.
   PubMed Web of Science ®Google Scholar
• Hendriksz CJ, Al-Jawad M, Berger KI, et al. Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA. J Inherit Metab Dis. 2013;36(2):309–322.
   PubMed Web of Science ®Google Scholar
• Sarmento A, Aliverti A, Marques L, et al. Multiparametric analysis of sniff nasal inspiratory pressure test in middle stage amyotrophic lateral sclerosis. Front Neurol. 2018;9:306.
   PubMed Web of Science ®Google Scholar
• Koulouris N, Vianna LG, Mulvey DA, et al. Maximal relaxation rates of esophageal, nose, and mouth pressures during a sniff reflect inspiratory muscle fatigue. Am Rev Respir Dis. 1989;139(5):1213–1217.
   PubMedGoogle Scholar
• Pennati F, Arrigoni F, LoMauro A, et al. Diaphragm involvement in Duchenne Muscular Dystrophy (DMD): an MRI study. J Magn Reson Imaging. 2020;51(2):461–471.
   PubMed Web of Science ®Google Scholar
• Rodriguez ME, Mackenzie WG, Ditro C, et al. Skeletal dysplasias: evaluation with impulse oscillometry and thoracoabdominal motion analysis. Pediatr Pulmonol. 2010;45(7):679–686.
   PubMed Web of Science ®Google Scholar
• Aliverti A, Ghidoli G, Dellacà RL, et al. Chest wall kinematic determinants of diaphragm length by optoelectronic plethysmography and ultrasonography. J Appl Physiol. 2003;94:621–630.
   Google Scholar
• Aliverti A, Pedotti A. Opto-electronic plethysmography. Monaldi Arch Chest Dis. 2003;59(1):12–16.
   PubMedGoogle Scholar
• LoMauro A, Pochintesta S, Romei M, et al. Rib cage deformities alter respiratory muscle action and chest wall function in patients with severe osteogenesis imperfecta. PLOS One. 2012;7(4):e35965.
   PubMed Web of Science ®Google Scholar
• Papastamelos C, Panitch HB, Allen JL. Chest wall compliance in infants and children with neuromuscular disease. Am J Respir Crit Care Med. 1996;154(4)Pt 1:1045–1048.
   PubMed Web of Science ®Google Scholar
• Romei M, Mauro AL, D'Angelo MG, et al. Effects of gender and posture on thoraco-abdominal kinematics during quiet breathing in healthy adults. Respir Physiol Neurobiol. 2010;172(3):184–191.
   PubMed Web of Science ®Google Scholar
• Fahy B, Sockrider M, Lareau S. Pulmonary function tests – ATS patient education serie. Am J Respir Crit Care Med. 2014;189:P17–P18.
   PubMedGoogle Scholar
• Medeiros AIC, Brandão DC, Souza RJP, et al. Effects of daily inspiratory muscle training on respiratory muscle strength and chest wall regional volumes in haemodialysis patients: a randomised clinical trial. Disabil Rehabil. 2019;41(26):3173–3180.
   PubMed Web of Science ®Google Scholar
• Muniz de Souza H, Rocha T, Campos SL, et al. Efeitos agudos de diferentes esforços inspiratórios no padrão ventilatório e distribuição compartimental da parede torácica em mulheres idosas. Respir Physiol Neurobiol. 2016; 227:27–33.
   PubMed Web of Science ®Google Scholar